Results

Total Results: 2,582 records

Showing results for "testing".

281. Renal-Function Research-Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/renal-function_research-protocol.pdf
     June 13, 2013 - Previous reviews and meta-analyses have investigated the prognostic performance of troponin testing … Note that for the population with suspected ACS (KQ 1-3), biomarker testing is done so routinely as … part of standard care that “no testing” is not a realistic comparator. … hs troponin I Troponin testing in CKD vs non-CKD Troponin testing vs. … • For the population with suspected ACS (KQ 1-3), biomarker testing is done so routinely as part

282. Trends in the use of echocardiography, 2007 to 2011 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/echocardiography_research.pdf
     May 01, 2014 - 12 The criteria vary by previous service and clinical indication, but in gen- eral echocardiography testing … unclear - in the case of stress echo- cardiography, the relationship between the office location of testing … material and increased cost of care after testing is modest.13 However, evidence indicates that physicians … : an empiric analysis of cardiac stress testing with imaging. … Repeat testing among Medicare beneficiaries. Arch Intern Med 2012;172(22):1745-51. 19.

283. Editorial. Methods Guide for Authors of Systematic Reviews of Medical Tests: A Collaboration Between the Agency for Healthcare Research and Quality (AHRQ) and the Journal of General Internal Medicine | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/methods-guide-editorial/methods
     December 01, 2019 - compared to a reference standard, in this case, invasive angiography) and the downstream result of testing

284. Imaging Techniques for the Surveillance, Diagnosis, and Staging of Hepatocellular Carcinoma | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/liver-cancer/research-protocol
     December 01, 2019 - Surveillance is the use of periodic testing to monitor lesions in the liver that give rise to a clinical … What are the adverse effects or harms associated with using imaging techniques related to testing or … Psychosocial effects of diagnostic testing on patients, patients’ caregivers, and other family members … Psychosocial effects of diagnostic testing on patients, patients’ caregivers, and other family members … Psychosocial effects of diagnostic testing on patients, patients’ caregivers, and other family members

285. Radon | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/radon
     Testing is the only way to know if your home has elevated radon levels. It is inexpensive and easy.

286. Methods Guide for Medical Test Reviews Chapter 9 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-performance_methods.pdf
     July 01, 2012 - screening performance of the test, it quantifies the impact of patient management strategies that include testing … PSA levels are not elevated in as many as 15 percent of individuals with prostate cancer, making PSA testing

287. Imaging Tests for the Diagnosis and Staging of Pancreatic Adenocarcinoma | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/cancer-pancreas/research-protocol
     January 01, 2020 - factors (e.g., Peutz-Jeghers syndrome, Lynch syndrome, and BRCA2, PALB2, and p16 mutations) motivate testing … Testing for recurrent pancreatic cancer is excluded. … diagnostic errors/ or exp diagnostic error/) 34 Pancreatic cancer and imaging and diagnostic testing

288. Troponin Cardiac Marker Interpretation During Renal Function Impairment | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/renal-function/research-protocol
     December 01, 2019 - Previous reviews and meta-analyses have investigated the prognostic performance of troponin testing in … as part of standard care that “no testing” is not a realistic comparator. … In KQ 4, one comparator of interest would be “no testing” beyond the use of a standard risk-predictor … For the population with suspected ACS (KQs 1–3), biomarker testing is done so routinely as part of a … standard workup that “no testing” is not a realistic comparator and thus will not be evaluated.

289. Frameworks for Determining Research Gaps During Systematic Reviews | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/methods-future-research-steps-framework/research
     December 01, 2019 - During pilot-testing, we identified challenges including difficulty in applying the framework for completed … Further testing should determine if these challenges are ameliorated if the framework is used during

290. Diagnosis and Management of Febrile Infants (0–3 Months) | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/febrile-infants-diagnosis-management/research
     December 01, 2019 - Harms associated with testing or management strategies have been less well studied. … Future studies should focus on identifying the risks associated with testing and management strategies

291. An Evidence Review of Active Surveillance in Men with Localized Prostate Cancer | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/prostate-cancer-surveillance/research
     December 01, 2019 - Increased diagnosis of early-stage prostate cancer due to prostate-specific antigen (PSA) testing, led … different monitoring protocols, all with different combinations of periodic digital rectal examination, PSA testing

292. Blood Count Tests | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/blood-count-tests
     November 09, 2009 - Report November 9, 2009 Additional Patient Outcomes and Alternative Pathways in Evaluations of Testing

293. Leukodystrophies | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/leukodystrophies
     Researchers are testing bone marrow transplantation as a treatment for some of the leukodystrophies.

294. Heart Diseases | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/heart-diseases?page=0
     June 21, 2018 - Diabetic Peripheral Neuropathy Systematic Review Archived March 29, 2016 Noninvasive Testing … Artery Stenosis Update Research Protocol Archived January 15, 2015 Noninvasive Testing

295. Heart Attack | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/heart-attack
     November 14, 2017 - Depression: A Systematic Review Systematic Review Archived March 29, 2016 Noninvasive Testing … Coronary Artery Disease Research Protocol Archived January 15, 2015 Noninvasive Testing

296. Heart Diseases | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/heart-diseases
     June 21, 2018 - Diabetic Peripheral Neuropathy Systematic Review Archived March 29, 2016 Noninvasive Testing … Artery Stenosis Update Research Protocol Archived January 15, 2015 Noninvasive Testing

297. Appendixes: Blood-based Tests for Multiple Cancer Screening: A Systematic Review (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cell-free-dna-appendices.pdf
     May 22, 2024 - stool-based tests (colorectal), low- dose computed tomography (lung), cytology, human papilloma virus testing … Sensitivity TP/(TP+FN) Proportion of persons with cancer testing positive on the MCST; ranges from … Specificity TN/(TN+FP) Proportion of persons without cancer testing negative on the MCST; ranges from … Early real-world experience with repeat multi- cancer early detection (MCED) testing. … Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention.

298. Technical Brief: Use and Safety of Positional MRI in the Management of Patients with Musculoskeletal Pain | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/musculoskeletal-disorders-imaging/research-protocol
     December 01, 2019 - What are the postulated advantages and disadvantages of positional MRI testing compared to contemporary … Guiding question 2: What is the current availability and cost of positional MRI testing and what are … Approximately how many facilities and of what kind are currently providing positional MRI testing in … used Study design and size Role of the test in patient management Setting where positional MRI testing … Moreover, we will record the outcomes being assessed in each study, including testing related harms,

299. Evaluating Practices and Developing Tools for Comparative Effectiveness Reviews of Diagnostic Test Accuracy: Methods for the Joint Meta-Analysis of Multiple Tests (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/diagnostic-tests-accuracy_research.pdf
     January 01, 2013 - algorithms in the frequentist and Bayesian settings, using approximate and discrete likelihoods to model testing … 1 Background The value of diagnostic testing for patient management ultimately derives from its effect … Testing primarily affects outcomes by indirect means, influencing downstream patient management decisions … , including decisions for further testing, and administration or choice of treatment. … screening programs do not rely on isolated markers, but combine sequential biochemical and ultrasound testing

300. Technical Brief Disposition of Comments Report for Gene Expression Profiling for Predicting Outcomes in Stage II Colon Cancer (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/colon-cancer-gene-profiling_disposition-comments.pdf
     December 14, 2012 - I did wonder why at several times the idea of only testing T3 tumors without MSI was mentioned instead … of suggesting that testing be restricted to all Stage II tumors without MSI but since it was just a … Most of the studies were for prognostic testing, but predictive testing is the more important clinical … in or..” such that the first sentence would be changed to, “Because the topic of this Brief is GEP testing … Clarification of “patients for testing” will be very important as clinical algorithms for use of GEP